Effect of intravenous infusion of a beta-adrenergic blocking agent on the haemodynamic changes in human masseter muscle induced by cold-pressor stimulation
K. Maekawa et al., Effect of intravenous infusion of a beta-adrenergic blocking agent on the haemodynamic changes in human masseter muscle induced by cold-pressor stimulation, ARCH ORAL B, 44(6), 1999, pp. 475-483
Eight healthy non-smoking males (mean age: 24.1 +/- 1.1 years) without any
history of chronic muscle pain and migraine participated in this study. Hae
moglobin (Hb) and oxygen (O-2) saturation in the right masseter muscle were
continuously recorded with a non-invasive near-infrared spectroscopic devi
ce. Heart rate and blood pressure were also recorded. The experiment had th
ree phases: a placebo drug (physiological saline) with cold-presser trial,
a 30-sec maximal voluntary clenching (MVC) trial, and a propranolol with co
ld-presser trial. The saline and drug trials each involved continuous recor
ding for 1 min before, 2 min during and 5 min after the cold-presser stimul
ation (4 degrees C). Physiological saline (20 ml) or propranolol hydrochlor
ide (20 ml) were infused at the rate of 2 ml/min. This infusion was begun 2
0 min before the baseline recording and participants did not know which sol
ution (saline or propranolol) was being infused. For the MVC trial, each pa
rticipant was asked to perform a 30-sec clench of their jaw-closing muscles
. There was a rest period of 15 min between each trial. The individual Hb a
nd O-2 data were normalized so that the baseline at the beginning of the ex
periment was equal to zero, and the Hb and O-2 data were normalized as a pe
rcentage of the individual's own highest absolute Hb and O-2 after and duri
ng the MVC, respectively. The results showed that the mean baseline Hb 1 mi
n before cold-presser stimulation was significantly lower in the beta-block
er trial than in the placebo trial (p = 0.035). The mean change in Hb from
baseline during cold-presser stimulation in the beta-blocker trial was also
significantly less than in the placebo trial (p = 0.035). The mean Hb rebo
und change after the cold-presser stimulation in the beta-blocker trial was
significantly higher than in the placebo trial, and no significant heart-r
ate differences were observed in the period after cold-presser stimulation.
Overall, the mean heart rate before and during that stimulation was signif
icantly lower in the beta-blocker trial than the placebo trial (p < 0.001).
There was no significant mean blood-pressure difference between placebo an
d beta-blocker trials at any time. These results suggest that beta-adrenoce
ptor blocking decreases the blood volume in the resting masseter, suppresse
s the incremental blood-volume change during cold-presser stimulation. and
discloses a hidden vasoconstrictive effect after that stimulation. (C) 1999
Published by Elsevier Science Ltd. All rights reserved.